VOLGA: A Phase III Randomized, Open-Label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab in Combination With Tremelimumab and Enfortumab Vedotin or Durvalumab in Combination With Enfortumab Vedotin for Perioperative

Project: Research

Status	Active
Effective start/end date	09/20/21 → 05/1/27

Project Details